New hope for healing Crohn's fistulas when other treatments fail

NCT ID NCT06918808

Recruiting now Disease control Sponsor: Direct Biologics, LLC Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a product made from stem cells (DB-3Q) can help heal painful fistulas in people with Crohn's disease. It is for adults whose fistulas have not improved with standard medications or surgery. The goal is to see if injections of this product are safe and can close the fistulas, as measured by both physical exam and MRI scans.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIANAL FISTULA DUE TO CROHN'S DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Columbia University Irving Medical Center/NYPH
RECRUITING

New York, New York, 10032, United States

Contact Email: •••••@•••••
Direct Biologics Investigational Site
RECRUITING

Aurora, Colorado, 80045, United States
Direct Biologics Investigational Site
RECRUITING

St Louis, Missouri, 63130, United States

Conditions

Explore the condition pages connected to this study.

PERIANAL FISTULA DUE TO CROHN'S DISEASE